Biomedicines · Nov 15, 2026
Lactate-to-Prealbumin Ratio Versus Lactate-to-Albumin Ratio for Predicting 28-Day Mortality in Octogenarians with Sepsis and Elevated Lactate
By Hirayama I, Nonaka M, Naraba H et al.
Background/Objective: The lactate-to-prealbumin ratio (LPR) has been proposed as a potential prognostic marker in sepsis. However, its prognostic performance compared with the lactate-to-albumin ratio (LAR) has not been established in older patients. This study compared LPR and LAR with respect to their association with 28-day mortality and discriminatory performance in older patients with sepsis and elevated lactate. Methods: This single-center retrospective cohort study included patients aged ≥75 years with sepsis and an initial serum lactate concentration of ≥2.0 mmol/L. The primary outcome was 28-day mortality. Prognostic performance was evaluated using Kaplan–Meier, Cox proportional hazards, and receiver operating characteristic (ROC) curve analyses. Exploratory subgroup analyses were performed according to age (≥86 years) and initial lactate concentration (>4 mmol/L). Results: Among 72 patients, 57 survived and 15 died within 28 days. Non-survivors had higher LAR and LPR values than survivors; serum lactate concentrations did not differ significantly between the groups. High LPR was associated with lower 28-day survival probability (log-rank p = 0.002) and remained significantly associated with mortality after adjustment for Sequential Organ Failure Assessment (SOFA) score (hazard ratio [HR], 4.90; 95% confidence interval [CI], 1.06–22.58; p = 0.042), whereas high LAR did not (HR, 1.60; 95% CI, 0.54–4.74; p = 0.401). The area under the ROC curve (AUC) was 0.785 for LPR and 0.702 for LAR, with a marginally significant difference between the two (DeLong test, p = 0.049). In the subgroup aged ≥86 years, the AUC was higher for LPR than for LAR (0.770 vs. 0.663; p = 0.043), whereas no significant difference was observed in patients with lactate concentrations >4 mmol/L (0.807 vs. 0.789; p = 0.834). Conclusions: In older patients with sepsis and an initial lactate concentration of ≥2.0 mmol/L, LPR showed a slightly higher discriminatory performance for 28-day mortality than LAR and remained independently associated with mortality after adjustment for SOFA score. These findings suggest a potential prognostic advantage of LPR over LAR in this specific population. Further validation in larger multicenter cohorts is warranted.